Beta-amyloid increases the expression level of ATBF1 responsible for death in cultured cortical neurons

Molecular Neurodegeneration

Volumn 6, Issue 1, 2011, Pages

  Jung, Cha Gyun ^a   Uhm, Kyung Ok ^a   Miura, Yutaka ^b   Hosono, Takashi ^a   Horike, Hirofumi ^a   Khanna, Kum Kum ^c   Kim, Mi Jeong ^a   Michikawa, Makoto ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE; AMYLOID BETA PROTEIN[1-42]; AT MOTIF BINDING FACTOR 1; ATM PROTEIN; CAFFEINE; CASPASE 3; CASPASE 7; CYCLIN DEPENDENT KINASE INHIBITOR 1; ETOPOSIDE; HOMOCYSTEINE; MESSENGER RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; MOUSE; MUTANT; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; UPREGULATION; WILD TYPE;

ATAXIA TELANGIECTASIA; MUS; MUS MUSCULUS; RATTUS;

EID: 79959820844     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-6-47     Document Type: Article

References (48)

1. Alzheimer's disease: genes, proteins, and therapy. DJ Selkoe, Physiol Rev 2001 81 741 766 11274343 (Pubitemid 32267077)
2. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. RE Tanzi L Bertram, Cell 2005 120 545 555 10.1016/j.cell.2005.02. 008 15734686 (Pubitemid 40269768)
3. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. A Goate MC Chartier-Harlin M Mullan J Brown F Crawford L Fidani L Giuffra A Haynes N Irving L James, et al. Nature 1991 349 704 706 10.1038/349704a0 1671712 (Pubitemid 21912142)
4. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. R Sherrington EI Rogaev Y Liang EA Rogaeva G Levesque M Ikeda H Chi C Lin G Li K Holman, et al. Nature 1995 375 754 760 10.1038/375754a0 7596406
5. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. EI Rogaev R Sherrington EA Rogaeva G Levesque M Ikeda Y Liang H Chi C Lin K Holman T Tsuda, et al. Nature 1995 376 775 778 10.1038/376775a0 7651536
6. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. AM Saunders WJ Strittmatter D Schmechel PH George-Hyslop MA Pericak-Vance SH Joo BL Rosi JF Gusella DR Crapper-MacLachlan MJ Alberts, et al. Neurology 1993 43 1467 1472 8350998 (Pubitemid 23230526)
7. Effects of injected Alzheimer beta-amyloid cores in rat brain. SA Frautschy A Baird GM Cole, Proc Natl Acad Sci USA 1991 88 8362 8366 10.1073/pnas.88.19.8362 1924295 (Pubitemid 21915356)
8. An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. NW Kowall MF Beal J Busciglio LK Duffy BA Yankner, Proc Natl Acad Sci USA 1991 88 7247 7251 10.1073/pnas.88.16.7247 1714596 (Pubitemid 21915127)
9. Amyloid beta peptide induces necrosis rather than apoptosis. C Behl JB Davis FG Klier D Schubert, Brain Res 1994 645 253 264 10.1016/0006-8993(94) 91659-4 8062088 (Pubitemid 24140132)
10. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. DT Loo A Copani CJ Pike ER Whittemore AJ Walencewicz CW Cotman, Proc Natl Acad Sci USA 1993 90 7951 7955 10.1073/pnas.90.17.7951 8367446 (Pubitemid 23260832)
11. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Busser DS Geldmacher K Herrup, J Neurosci 1998 18 2801 2807 9525997 (Pubitemid 28163210)
12. Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments. WK Liu RT Williams FL Hall DW Dickson SH Yen, Am J Pathol 1995 146 228 238 7856730
13. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. A McShea PL Harris KR Webster AF Wahl MA Smith, Am J Pathol 1997 150 1933 1939 9176387 (Pubitemid 27233067)
14. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. I Vincent G Jicha M Rosado DW Dickson, J Neurosci 1997 17 3588 3598 9133382 (Pubitemid 27200586)
15. Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? A Copani D Uberti MA Sortino V Bruno F Nicoletti M Memo, Trends Neurosci 2001 25 31 (Pubitemid 32332893)
16. Increased p27, an essential component of cell cycle control, in Alzheimer's disease. O Ogawa HG Lee X Zhu A Raina PL Harris RJ Castellani G Perry MA Smith, Aging Cell 2003 2 105 110 10.1046/j.1474-9728.2003.00042.x 12882323
17. BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease. TA Evans AK Raina A Delacourte O Aprelikova HG Lee X Zhu G Perry MA Smith, Int J Med Sci 2007 140 145 (Pubitemid 46743287)
18. Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease. G Cenini R Sultana M Memo DA Butterfield, Free Radic Biol Med 2008 45 81 85 10.1016/j.freeradbiomed.2008.03.015 18439434
19. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. K Hsiao P Chapman S Nilsen C Eckman Y Harigaya S Younkin F Yang G Cole, Science 1996 274 99 102 10.1126/science.274.5284.99 8810256 (Pubitemid 26332733)
20. Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. Y Yang NH Varvel BT Lamb K Herrup, J Neurosci 2006 26 775 784 10.1523/JNEUROSCI.3707-05.2006 16421297 (Pubitemid 43237070)
21. Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides. JP Lopes CR Oliveira P Agostinho, Cell Cycle 2009 8 97 104 10.4161/cc.8.1.7506 19158499
22. Cell cycle activation linked to neuronal cell death initiated by DNA damage. RP Wersto F Cardozo-Pelaez L Smilenov SL Chan FJ Chrest R Emokpae Jr M Gorospe MP Mattson, Neuron 2004 41 549 561 10.1016/S0896-6273(04)00017-0 14980204 (Pubitemid 38253067)
23. Cloning and characterization of an ATBF1 isoform that expresses in a neuronal differentiation-dependent manner. Y Miura T Tam A Ido T Morinaga T Miki T Hashimoto T Tamaoki, J Biol Chem 1995 270 26840 26848 10.1074/jbc.270.45. 26840 7592926
24. A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers. T Morinaga H Yasuda T Hashimoto K Higashio T Tamaoki, Mol Cell Biol 1991 11 6041 6049 1719379 (Pubitemid 21895375)
25. Homeotic factor ATBF1 induces the cell cycle arrest associated with neuronal differentiation. CG Jung HJ Kim M Kawaguchi KK Khanna H Hida K Asai H Nishino Y Miura, Development 2005 132 5137 5145 10.1242/dev.02098 16251211 (Pubitemid 43020170)
26. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. S Matsuoka BA Ballif A Smogorzewska ER McDonald KE Hurov J Luo CE Bakalarski Z Zhao N Solimini Y Lerenthal, et al. Science 2007 316 1160 1166 10.1126/science.1140321 17525332 (Pubitemid 46877472)
27. Susceptibility to killer T cells of gastric cancer cells enhanced by Mitomycin-C involves induction of ATBF1 and activation of p21 (Waf1/Cip1) promoter. Y Miura H Kataoka T Joh T Tada K Asai M Nakanishi N Okada H Okada, Microbiol Immunol 2004 48 137 145 14978340 (Pubitemid 38248341)
28. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. X Sun HF Frierson C Chen C Li Q Ran KB Otto BL Cantarel RL Vessella AC Gao J Petros, et al. Nat Genet 2005 37 407 412 10.1038/ng1528 15750593
29. ATBF1 inhibits ER function by selectively competing with AIB1 for binding to ER in ER-positive breast cancer cells. XY Dong X Sun P Guo Q Li M Sasahara Y Ishii JT Dong, J Biol Chem 285 43 32801 9
30. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. T Kawarabayashi LH Younkin TC Saido M Shoji KH Ashe SG Younkin, J Neurosci 2001 21 372 381 11160418 (Pubitemid 32107428)
31. Radiation- and chemical-induced structural chromosome aberrations in human spermatozoa. Y Kamiguchi H Tateno, Mutat Res 2002 504 183 191 12106658 (Pubitemid 34775111)
32. Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. KA Roth, J Neuropathol Exp Neurol 2001 60 829 838 11556539
33. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair. HE Bryant T Helleday, Nucleic Acids Res 2006 34 1685 1691 10.1093/nar/gkl108 16556909
34. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. D Tang D Wu A Hirao JM Lahti L Liu B Mazza VJ Kidd TW Mak AJ Ingram, J Biol Chem 2002 277 12710 12717 10.1074/jbc.M111598200 11821415 (Pubitemid 34952631)
35. Cell cycle molecules and vertebrate neuron death: E2F at the hub. LA Greene SC Biswas DX Liu, Cell Death Differ 2004 11 49 60 10.1038/sj.cdd.4401341 14647236 (Pubitemid 38111372)
36. Divide and die: cell cycle events as triggers of nerve cell death. K Herrup R Neve SL Ackerman A Copani, J Neurosci 2004 24 9232 9239 10.1523/JNEUROSCI.3347-04.2004 15496657 (Pubitemid 39426158)
37. Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. A Nunomura PI Moreira HG Lee X Zhu RJ Castellani MA Smith G Perry, CNS Neurol Disord Drug Targets 2007 6 411 423 10.2174/187152707783399201 18220780 (Pubitemid 351486255)
38. Cell cycle machinery and stroke. J Rashidian GO Iyirhiaro DS Park, Biochim Biophys Acta 2007 1772 484 493 17241774 (Pubitemid 46400387)
39. Ataxia telangiectasia-mutated protein can regulate p53 and neuronal death independent of Chk2 in response to DNA damage. E Keramaris A Hirao RS Slack TW Mak DS Park, J Biol Chem 2003 278 37782 37789 10.1074/jbc.M304049200 12857758 (Pubitemid 37175305)
40. Molecular basis of programmed cell death involved in neurodegeneration. S Krantic N Mechawar S Reix R Quirion, Trends Neurosci 2005 28 670 676 10.1016/j.tins.2005.09.011 16216345 (Pubitemid 41654391)
41. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. EU Kurz SP Lees-Miller, DNA Repair (Amst) 2004 3 889 900 10.1016/j.dnarep.2004.03.029 (Pubitemid 38997931)
42. Activation of DNA damage signaling. M Ljungman, Mutat Res 2005 577 203 216 15922368 (Pubitemid 41225500)
43. Ataxia telangiectasia: new neurons and ATM. PJ McKinnon, Trends Mol Med 2001 7 233 234 10.1016/S1471-4914(01)02035-4 11378498 (Pubitemid 32545512)
44. Involvement of DNA damage and repair systems in neurodegenerative process. D Uberti G Ferrari Toninelli M Memo, Toxicol Lett 2003 139 99 105 10.1016/S0378-4274(02)00423-X 12628744 (Pubitemid 36298967)
45. A novel action of alzheimer's amyloid beta-protein (Abeta): oligomeric Abeta promotes lipid release. M Michikawa JS Gong QW Fan N Sawamura K Yanagisawa, J Neurosci 2001 21 7226 7235 11549733 (Pubitemid 32846970)
46. Cellular and molecular characteristics of an immortalized ataxia-telangiectasia (group AB) cell line. Y Ziv NG Jaspers S Etkin T Danieli L Trakhtenbrot A Amiel Y Ravia Y Shiloh, Cancer Res 1989 49 2495 2501 2539904 (Pubitemid 19125584)
47. Recombinant ATM protein complements the cellular A-T phenotype. Y Ziv A Bar-Shira I Pecker P Russell TJ Jorgensen I Tsarfati Y Shiloh, Oncogene 1997 15 159 167 10.1038/sj.onc.1201319 9244351 (Pubitemid 27344555)
48. ATBF1 enhances the suppression of STAT3 signaling by interaction with PIAS3. S Nojiri T Joh Y Miura N Sakata T Nomura H Nakao S Sobue H Ohara K Asai M Ito, Biochem Biophys Res Commun 2004 314 97 103 10.1016/j.bbrc.2003.12.054 14715251 (Pubitemid 38058374)